G Vairo

3.9k total citations
49 papers, 2.8k citations indexed

About

G Vairo is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, G Vairo has authored 49 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 22 papers in Immunology and 17 papers in Oncology. Recurrent topics in G Vairo's work include Immune Cell Function and Interaction (10 papers), Immune cells in cancer (10 papers) and Immune Response and Inflammation (9 papers). G Vairo is often cited by papers focused on Immune Cell Function and Interaction (10 papers), Immune cells in cancer (10 papers) and Immune Response and Inflammation (9 papers). G Vairo collaborates with scholars based in Australia, United States and Canada. G Vairo's co-authors include John A. Hamilton, Doron Ginsberg, David M. Livingston, Jerry M. Adams, Samantha J. Busfield, James A. DeCaprio, Angel F. López, Hayley S. Ramshaw, Richard B. Lock and Karen L. Wydner and has published in prestigious journals such as Journal of Biological Chemistry, Genes & Development and Blood.

In The Last Decade

G Vairo

48 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Vairo Australia 29 1.5k 1.3k 926 476 335 49 2.8k
Brent L. Kreider United States 26 1.4k 0.9× 1.1k 0.8× 1.1k 1.2× 420 0.9× 194 0.6× 44 2.9k
Tetsuya Yamagata Japan 25 1.2k 0.8× 499 0.4× 1.1k 1.1× 618 1.3× 260 0.8× 58 2.7k
Mary L. Bath Australia 22 2.0k 1.3× 1.2k 0.9× 1.3k 1.4× 379 0.8× 339 1.0× 30 3.5k
Kazushi Inoue United States 34 2.7k 1.8× 1.5k 1.2× 412 0.4× 552 1.2× 450 1.3× 79 3.7k
Olle Sangfelt Sweden 31 2.3k 1.5× 1.3k 1.0× 691 0.7× 334 0.7× 553 1.7× 51 3.4k
Annalisa Frattini Italy 26 2.0k 1.3× 1.0k 0.8× 1.0k 1.1× 181 0.4× 307 0.9× 77 3.4k
Stephan Teglund Sweden 15 2.0k 1.3× 1.8k 1.4× 1.1k 1.2× 386 0.8× 366 1.1× 23 3.9k
RA Ashmun United States 19 1.1k 0.7× 976 0.7× 487 0.5× 378 0.8× 268 0.8× 31 2.3k
Rebecca J. Chan United States 32 2.2k 1.4× 531 0.4× 917 1.0× 580 1.2× 219 0.7× 90 3.3k
Maya Dajee United States 15 1.2k 0.8× 628 0.5× 434 0.5× 305 0.6× 354 1.1× 23 2.0k

Countries citing papers authored by G Vairo

Since Specialization
Citations

This map shows the geographic impact of G Vairo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Vairo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Vairo more than expected).

Fields of papers citing papers by G Vairo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Vairo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Vairo. The network helps show where G Vairo may publish in the future.

Co-authorship network of co-authors of G Vairo

This figure shows the co-authorship network connecting the top 25 collaborators of G Vairo. A scholar is included among the top collaborators of G Vairo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Vairo. G Vairo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Liji, Mark Biondo, Samantha J. Busfield, et al.. (2017). CD123 target validation and preclinical evaluation of ADCC activity of anti-CD123 antibody CSL362 in combination with NKs from AML patients in remission. Blood Cancer Journal. 7(6). e567–e567. 36 indexed citations
2.
Oon, Shereen, Huy Huynh, Tsin Yee Tai, et al.. (2016). A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus. JCI Insight. 1(6). e86131–e86131. 26 indexed citations
3.
McManus, Julie F., Nik Cummings, G Vairo, et al.. (2015). Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice. Haematologica. 100(7). 914–926. 51 indexed citations
4.
Busfield, Samantha J., Mark Biondo, Hayley S. Ramshaw, et al.. (2014). Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCC. Leukemia. 28(11). 2213–2221. 106 indexed citations
5.
Nievergall, Eva, John Reynolds, Chung Hoow Kok, et al.. (2014). High Plasma Levels of TGF-α and IL-6 at Diagnosis Predict Early Molecular Response Failure and Transformation in CML. Blood. 124(21). 1788–1788.
6.
Jin, Liqing, Erwin M. Lee, Hayley S. Ramshaw, et al.. (2009). Monoclonal Antibody-Mediated Targeting of CD123, IL-3 Receptor α Chain, Eliminates Human Acute Myeloid Leukemic Stem Cells. Cell stem cell. 5(1). 31–42. 390 indexed citations
7.
Vadiveloo, Peter K, G Vairo, Paul J. Hertzog, Ismail Kola, & John A. Hamilton. (2000). ROLE OF TYPE I INTERFERONS DURING MACROPHAGE ACTIVATION BY LIPOPOLYSACCHARIDE. Cytokine. 12(11). 1639–1646. 55 indexed citations
8.
Cambier, Nathalie, et al.. (1999). Expression of BCR – ABL in M1 myeloid leukemia cells induces differentiation without arresting proliferation. Oncogene. 18(2). 343–352. 12 indexed citations
9.
Adams, Jerry M., David C.S. Huang, Hamsa Puthalakath, et al.. (1999). Control of Apoptosis in Hematopoietic Cells by the Bcl-2 Family of Proteins. Cold Spring Harbor Symposia on Quantitative Biology. 64(0). 351–358. 30 indexed citations
10.
Vadiveloo, Peter K, et al.. (1998). Proliferation-independent Induction of Macrophage Cyclin D2, and Repression of Cyclin D1, by Lipopolysaccharide. Journal of Biological Chemistry. 273(36). 23104–23109. 19 indexed citations
11.
Whyatt, David, Alar Karis, Anton Verkerk, et al.. (1997). The level of the tissue‐specific factor GATA‐1 affects the cell‐cycle machinery. PubMed. 1(1). 11–24. 57 indexed citations
12.
Vairo, G & John A. Hamilton. (1993). Evidence against a requirement for Na+/H+ exchange activity for proliferation or differentiation of HL60 leukemic cells.. PubMed. 4(6). 461–6. 6 indexed citations
14.
Knight, K.R., G Vairo, John A. Hamilton, & Diana A. Lepore. (1992). Coumarins: macrophage proteinase production and pinocytosis. Research in Experimental Medicine. 192(1). 99–103. 3 indexed citations
15.
Vairo, G, Benjamin G. Cocks, E. J. Cragoe, & John A. Hamilton. (1992). Selective suppression of growth factor-induced cell cycle gene expression by Na+/H+ antiport inhibitors.. Journal of Biological Chemistry. 267(27). 19043–19046. 33 indexed citations
18.
Hamilton, John A., et al.. (1988). Activation and proliferation signals in murine macrophages: Stimulation of glucose uptake by hemopoietic growth factors and other agents. Journal of Cellular Physiology. 134(3). 405–412. 78 indexed citations
19.
Vairo, G & John A. Hamilton. (1988). Activation and proliferation signals in murine macrophages: Stimulation of Na+, K+‐ATPase activity by hemopoietic growth factors and other agents. Journal of Cellular Physiology. 134(1). 13–24. 67 indexed citations
20.
Burgess, Antony W., D Metcalf, I J Kozka, et al.. (1985). Purification of two forms of colony-stimulating factor from mouse L-cell-conditioned medium.. Journal of Biological Chemistry. 260(29). 16004–16011. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026